ACT | The App Association
FDANonrulemakingFDA-2021-D-0789

Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials; Draft Guidance for Industry; Availability

RIN
Last modified
Jul 29, 2025
Comment window
closed 670d ago
ACT | The App Association filings
1

Activity

ACT | The App Association filed 1 comment on this docket between Jun 13, 2022 and Jun 13, 2022. 87 other organizations filed here. The comment window closed 670d ago.

What ACT | The App Association filed (1)

Jun 13, 2022· Comment from ACT | The App Association· FDA-2021-D-0789-0070

Connected Health Initiative Comments on the Food and Drug Administration's Draft Guidance for Industry on "Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials" [Docket No. FDA-2021-D-0789]

Abstract

OPEN

View on regulations.gov →